Larvol Delta - CA224056-Study-of-Safety-and-Tolerability-of-Nivolumab-Treatment-Alone-or-in-Combination-With-Relatlimab-or-Ipilimumab-in-Head-and-Neck-Cancer

relatlimab (BMS-986016) - BMS

Yervoy (ipilimumab) - BMS

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

http://clinicaltrials.gov/ct2/show/NCT04080804

Sep 10, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next